PointState Capital
SGYP

PointState Capital’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

PointState Capital’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-566,192
Closed -$3M – 116
2015
Q3 		$3M Buy
+566,192
New +$4.38M 0.08% 73

Other funds holding SGYP

Paulson & Co
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock Fund Advisors
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock Institutional Trust
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
OrbiMed
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

PointState Capital's SGYP Position: Q4 2015 in Review

PointState Capital sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q4 2015, closing a stake of 566,192 shares — an estimated $3M sold.

PointState Capital first reported a position in SGYP in Q3 2015 and held it in 1 quarter. The position peaked at $3M in Q3 2015. 127 funds tracked by Wall St. Rank hold SGYP as of Q4 2015.

  • PointState Capital reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q4 2015 after selling out during the quarter.
  • PointState Capital sold 566,192 Synergy Pharmaceuticals, Inc Common Stock shares in Q4 2015, an estimated $3M.
  • PointState Capital first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q3 2015 and held it in 1 quarter.
  • PointState Capital's Synergy Pharmaceuticals, Inc Common Stock position peaked at $3M in Q3 2015.
  • 127 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q4 2015.

Based on PointState Capital's 13F filing for Q4 2015, filed 16 Feb 2016.